Understanding how Medicaid's approval process affects access to quitting smoking medications
Official title: Examining the Impact of Medicaid's Prior Authorization Requirements for Tobacco Cessation Medications on Tobacco Cessation Medication Prescriptions
Funded at Vanderbilt University · NIH-10758252 · Data updated 2026-11-12
This study looks at how the rules for getting tobacco quitting medications through Medicaid affect low-income smokers in Colorado, to see if making it easier to access these treatments can help more people quit smoking.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University NIH-funded |
| Lab location | 1 site (Nashville, UNITED STATES) |
| Project start | January 1, 2023 |
| Project end | December 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $79,250 |
| NIH project number | 5R03CA270451-02 |
| Project ID | NIH-10758252 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are low-income smokers enrolled in Medicaid who are seeking assistance with quitting smoking.
✕Less likely to help
Patients who are not enrolled in Medicaid or who do not smoke may not receive any benefit from this research.
What this research studies
This research investigates how Medicaid's prior authorization requirements for tobacco cessation medications impact the ability of low-income smokers to access these vital treatments. By analyzing health care claims data from Colorado's Medicaid program, the study aims to determine whether these requirements hinder or help the prescribing of cessation medications. The goal is to provide insights into whether removing such barriers can improve access to smoking cessation resources for those who need them most.
Why it matters
Potential benefit: If successful, this research could lead to improved access to tobacco cessation medications for low-income individuals, potentially increasing smoking cessation rates.
How similar studies have gone: Previous research has indicated that reducing barriers to medication access can significantly improve treatment outcomes, suggesting that this approach may yield beneficial results.
Where this research is happening
-
Vanderbilt University
Nashville, United States Active
Researchers
- Principal investigator: Dillender, Marcus Owen — Vanderbilt University
- Study coordinator: Dillender, Marcus Owen
Related research
Other NIH-funded projects on the same topics.
-
Understanding how peer norms around alcohol and HIV prevention affect adolescents and young adults in rural Uganda
This project studies how what young people think their peers do or approve of influences drinking and HIV prevention behaviors in rural Uganda, with the goal of improving health outcomes.
-
Cancer Pain Management for Asian American Breast Cancer Survivors with Depressive Symptoms
A technology-based program helps Asian American breast cancer survivors with depressive symptoms manage chronic pain more effectively from home using a web app and mobile tools.
-
Targeted gene silencing in the brain using siRNA helpers
This grant tests a new way to turn off specific brain genes in particular CNS cell types using siRNA conjugates to help understand brain biology and disease.
-
RSELVES Study: How older couples influence daily life and function with Alzheimer’s risk
A study to understand how daily routines and support between older adults and their partners relate to the development of Alzheimer’s-related functional decline.
-
Molecular mechanisms of coat assembly and regulation in membrane trafficking
A research project seeks to understand how cellular coats organize and regulate the delivery of membrane-bound cargo, with a focus on proteins related to neurological diseases.
-
Synaptic nanostructure in neurodevelopmental disorders
This project aims to map the tiny architecture of brain synapses in native cells to understand how connections form and change in neurodevelopmental disorders.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.